title: The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
abstract: Recombinant activated factor VII (rFVIIa) was first used to control bleeding in haemophilia patients. More recently, it has been used to prevent severe bleeding in patients without pre-existing coagulopathy. We report a case where rFVIIa was used to successfully control postoperative bleeding in a patient undergoing suprarenal abdominal aortic aneurysm (AAA) repair.
authors.affiliation: Department of Vascular Surgery, Karolinska Hospital, 171 76 Stockholm, Sweden.
authors.forename: C-M
authors.initials: CM
authors.lastname: Wahlgren
authors.forename: J
authors.initials: J
authors.lastname: Swedenborg
mesh_terms: D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D016063:Blood Loss, Surgical; D015942:Factor VIIa / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa